DeepMed Research

Royal Marsden NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.royalmarsden.nhs.uk

Clinical Trials

Pilot Study for 3-Dimensional Surface Imaging in Implant-based Breast Reconstruction

Conditions: Breast Cancer

First Posted Date: 2017-06-29

Last Posted Date: 2017-06-29

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 50

Registration Number: NCT03203252

Locations: 🇬🇧
Royal Marsden Hospital, Sutton, Surrey, United Kingdom

A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer

Phase 1

Terminated

Conditions: Cervix Cancer

Interventions: Combination Product: Pembrolizumab

First Posted Date: 2017-05-08

Last Posted Date: 2019-06-12

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 1

Registration Number: NCT03144466

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

Surgical Anatomy and 'Waisting' of the sIgmoid SpEcimen

Completed

Conditions: Sigmoid, Sigmoid Colon, Neoplasm, Cancer

First Posted Date: 2017-05-01

Last Posted Date: 2018-09-14

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 20

Registration Number: NCT03135808

Locations: 🇬🇧
Royal Marsden Hospital, London, United Kingdom

Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma

Phase 1

Conditions: Sarcoma

Interventions: Drug: Pembrolizumab
Drug: Gemcitabine

First Posted Date: 2017-04-21

Last Posted Date: 2021-06-30

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 24

Registration Number: NCT03123276

Locations: 🇬🇧
Royal Marsden, London, United Kingdom

Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction

Conditions: Breast Cancer

Interventions: Other: 3D surface imaging
Other: semi-structured interview
Other: applanation tonometry

First Posted Date: 2017-03-07

Last Posted Date: 2017-04-04

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 300

Registration Number: NCT03072316

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing

Conditions: Cytopenia

First Posted Date: 2017-01-20

Last Posted Date: 2017-08-28

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 285

Registration Number: NCT03026751

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: Regorafenib

First Posted Date: 2017-01-05

Last Posted Date: 2021-05-03

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 49

Registration Number: NCT03010722

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust London and Surrey, Carshalton, Surrey, United Kingdom

Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Phase 1

Recruiting

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Guadecitabine
Drug: ASTX727
Drug: Pembrolizumab

First Posted Date: 2016-12-20

Last Posted Date: 2025-05-04

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 34

Registration Number: NCT02998567

Locations: 🇬🇧
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
🇬🇧
UCLH, London, United Kingdom

PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: Cetuximab

First Posted Date: 2016-12-16

Last Posted Date: 2016-12-19

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 47

Registration Number: NCT02994888

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Surrey, Sutton, United Kingdom

A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy

Phase 2

Recruiting

Conditions: Cancer

Interventions: Device: ProSpare

First Posted Date: 2016-11-30

Last Posted Date: 2021-04-19

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 245

Registration Number: NCT02978014

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
🇬🇧
Cambridge University Hospitals, Cambridge, United Kingdom
🇬🇧
Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy